|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9-10
|
|
pubmed:dateCreated |
2004-7-7
|
|
pubmed:abstractText |
Cystic fibrosis is a well acknowledged indication for lung transplantation; however, the optimal timing for transplantation remains debatable. Liou et al. described a score for calculating 5-year probability of survival for patients with cystic fibrosis and concluded that only patients with a probability of survival < 30% gained a survival benefit from transplantation; those between 30% and 50% had equivocal survival effects from transplantation and those > 50% suffered negative effects. The aim of the present study was to determine the validity and applicability of this model.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0043-5325
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
318-21
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15237657-Actuarial Analysis,
pubmed-meshheading:15237657-Adolescent,
pubmed-meshheading:15237657-Adult,
pubmed-meshheading:15237657-Austria,
pubmed-meshheading:15237657-Cystic Fibrosis,
pubmed-meshheading:15237657-Disease-Free Survival,
pubmed-meshheading:15237657-Female,
pubmed-meshheading:15237657-Forced Expiratory Volume,
pubmed-meshheading:15237657-Humans,
pubmed-meshheading:15237657-Lung Transplantation,
pubmed-meshheading:15237657-Male,
pubmed-meshheading:15237657-Outcome Assessment (Health Care),
pubmed-meshheading:15237657-Probability,
pubmed-meshheading:15237657-Risk Assessment,
pubmed-meshheading:15237657-Survival Analysis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cystic fibrosis and lung transplantation--determination of the survival benefit.
|
|
pubmed:affiliation |
Department of Cardiothoracic Surgery, Vienna University Hospital, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
